Picturing an end to Alzheimer’s
After decades of disappointments, a potential breakthrough treatment for Alzheimer’s disease is sparking a new symptom in researchers, clinicians, caregivers and families: hope....
After decades of disappointments, a potential breakthrough treatment for Alzheimer’s disease is sparking a new symptom in researchers, clinicians, caregivers and families: hope....
Recently published results from a clinical trial showed that for critically ill adults needing tracheal intubation for emergency airway support, the method health care providers choose to use for providing supplemental oxygen before the intubation procedure affects the patient’s risk of hypoxemia, or potentially life-threatening...
By prioritizing quality in clinical research, organizations aspire to enhance their competitive edge, reduce costs through efficient processes, and foster a culture of excellence....
Cystic fibrosis is a hereditary condition, occurring in approximately one in 4,000 births. It causes normally slippery fluids in lungs and digestive system organs to become thick and sticky, resulting in lung and digestive impairment, risk of severe lung infections, malnutrition, and death....
The tests offer a fast and easy way for physicians to learn whether a patient with symptoms of cognitive decline also has the brain changes associated with Alzheimer’s. Evidence of those brain changes is required before doctors can prescribe one of two recently approved drugs...
The filters of modern news media create disparate, personalized perceptions of science. Researchers at CALS are looking for ways to craft messages that resonate with people of all viewpoints....
Hosting a robust onboarding process for introducing entry-level hires to their job responsibilities is clearly a best practice for any industry. Taking things one step further by onboarding both new and promoted employees who are at any step on their career ladder is proving to...
The US Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older....
Today, the summit organizers, UW Health and Epic, published a report detailing key recommendations for policymakers as they consider the future of AI in health care....
A combined blood test for cognitive decline has a 90% accuracy rate in determining whether memory loss is due to Alzheimer’s disease, a new study found....